Carbapenem-based Antibiotics Market Demand

Carbapenem-based Antibiotics Market to reach a valuation of US$1.8 Bn by 2029 | Merck Co. & Inc., Pfizer Inc

2021-03-15 // 0 Comments

Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. [read full press release…]

Carbapenem-based Antibiotics Market: Key Factors Impacting Growth Insights 2019 to 2029

2020-04-10 // 0 Comments

Increase in prevalence of bacterial infection across the globe as become an opportunity for many. It generates lucrative option for revenue generation for the stake [read full press release…]